333 related articles for article (PubMed ID: 1540262)
21. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry.
Terstappen LW; Loken MR
Anal Cell Pathol; 1990 Jul; 2(4):229-40. PubMed ID: 1703434
[TBL] [Abstract][Full Text] [Related]
22. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells.
Terstappen LW; Safford M; Unterhalt M; Könemann S; Zurlutter K; Piechotka K; Drescher M; Aul C; Büchner T; Hiddemann W
Leukemia; 1992 Oct; 6(10):993-1000. PubMed ID: 1383649
[TBL] [Abstract][Full Text] [Related]
24. HLA-DR antigen-negative acute myeloid leukemia.
Wetzler M; McElwain BK; Stewart CC; Blumenson L; Mortazavi A; Ford LA; Slack JL; Barcos M; Ferrone S; Baer MR
Leukemia; 2003 Apr; 17(4):707-15. PubMed ID: 12682628
[TBL] [Abstract][Full Text] [Related]
25. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells.
Lin LI; Chen CY; Lin DT; Tsay W; Tang JL; Yeh YC; Shen HL; Su FH; Yao M; Huang SY; Tien HF
Clin Cancer Res; 2005 Feb; 11(4):1372-9. PubMed ID: 15746035
[TBL] [Abstract][Full Text] [Related]
26. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies.
Marinov J; Koubek K; Starý J
Neoplasma; 1993; 40(6):355-8. PubMed ID: 8289967
[TBL] [Abstract][Full Text] [Related]
28. Intracellular markers in acute myeloid leukemia diagnosis.
Koníková E; Glasová M; Kusenda J; Babusíková O
Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
[TBL] [Abstract][Full Text] [Related]
29. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J
Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic quantitative features of patients with acute myeloid leukemia.
Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
[TBL] [Abstract][Full Text] [Related]
31. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
32. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
[TBL] [Abstract][Full Text] [Related]
33. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
Mesárosová A; Hrivnáková A; Babusíková O
Neoplasma; 1993; 40(6):341-5. PubMed ID: 8289964
[TBL] [Abstract][Full Text] [Related]
34. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
35. Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+).
Raymakers R; Wittebol S; Pennings A; Linders E; Poddighe P; De Witte T
Leukemia; 1995 Mar; 9(3):450-7. PubMed ID: 7533867
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
[TBL] [Abstract][Full Text] [Related]
37. Detection of minimal residual disease in acute myeloid leukemia.
Gerhartz HH; Schmetzer H
Leukemia; 1990 Jul; 4(7):508-16. PubMed ID: 1695705
[TBL] [Abstract][Full Text] [Related]
38. The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases.
Dunphy CH; Tang W
Arch Pathol Lab Med; 2007 May; 131(5):748-54. PubMed ID: 17488160
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease.
Macedo A; Orfao A; Ciudad J; Gonzalez M; Vidriales B; Lopez-Berges MC; Martínez A; Landolfi C; Cañizo C; San Miguel JF
Leukemia; 1995 Nov; 9(11):1896-901. PubMed ID: 7475281
[TBL] [Abstract][Full Text] [Related]
40. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
Paietta E; Andersen J; Gallagher R; Bennett J; Yunis J; Cassileth P; Rowe J; Wiernik PH
Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
